Successful treatment with sumatriptan in a case with cyclic vomiting syndrome combined with 18q- syndrome

J Child Neurol. 2009 Dec;24(12):1561-3. doi: 10.1177/0883073809334384. Epub 2009 Sep 30.

Abstract

The authors present a 14-year-old girl with 18q- syndrome combined with cyclic vomiting syndrome. Since the age of 5 years, she has been admitted to hospital 30 times. Despite trying many prophylactic treatments, no medication has inhibited the vomiting attacks successfully. Intranasal sumatriptan was effective at halting the vomiting attacks. This is the first case of 18q- syndrome combined with cyclic vomiting syndrome successfully treated with sumatriptan. This report may allow us to consider sumatriptan use in patients suffering from misery attack of cyclic vomiting syndrome combined with chromosomal abnormality of 18q- syndrome.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intranasal
  • Adolescent
  • Adrenal Cortex / metabolism
  • Adrenal Cortex / physiopathology
  • Brain / drug effects
  • Brain / physiopathology
  • Chromosome Disorders / complications*
  • Chromosome Disorders / genetics
  • Chromosome Disorders / physiopathology
  • Chromosomes, Human, Pair 18 / genetics
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Intellectual Disability / complications
  • Intellectual Disability / genetics
  • Intellectual Disability / physiopathology
  • Nervous System Malformations / complications*
  • Nervous System Malformations / genetics
  • Nervous System Malformations / physiopathology
  • Serotonin Receptor Agonists / administration & dosage*
  • Sumatriptan / administration & dosage*
  • Syndrome
  • Treatment Outcome
  • Vomiting / drug therapy*
  • Vomiting / genetics
  • Vomiting / physiopathology

Substances

  • Serotonin Receptor Agonists
  • Sumatriptan